Atlas Trials

Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease

Clinical trial NCT00102921 · COMPLETED

Trial details

NCT number
NCT00102921
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Crohn Disease
Start date
2004-08-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.